Method for reducing the content of an unsaturated amine in a mixture containing an amine and a nitrile

    公开(公告)号:AU3321302A

    公开(公告)日:2002-06-11

    申请号:AU3321302

    申请日:2001-11-29

    Applicant: BASF AG

    Abstract: A process is provided for reducing the content of a monounsaturated aliphatic amine (III) in a mixture (IV) containing an aminonitrile (I) or a diamine (II), or mixtures thereof, and the amine (III), whereina) the mixture (IV) is reacted with an anionic nucleophile (V),which contains a nucleophilic atom selected from the group comprising oxygen, nitrogen and sulfur,which is capable of taking up an H ion to form an acid with a pKa ranging from 7 to 11, measured in water at 25° C., andwhich has a relative nucleophilicity, measured in methyl perchlorate/methanol at 25° C.,ranging from 3.4 to 4.7 when oxygen is the nucleophilic atom,ranging from 4.5 to 5.8 when nitrogen is the nucleophilic atom, andranging from 5.5 to 6.8 when sulfur is the nucleophilic atom,in an amount ranging from 0.01 to 10 mol per mole of amine (III) in the mixture (IV), to give a mixture (VI), andb) the aminonitrile (I) or the diamine (II), or mixtures thereof, are distilled from the mixture (VI) at a temperature ranging from 50 to 170° C. and a pressure ranging from 0.5 to 100 kPa.

    85.
    发明专利
    未知

    公开(公告)号:DE59702349D1

    公开(公告)日:2001-10-31

    申请号:DE59702349

    申请日:1997-04-03

    Applicant: BASF AG

    Abstract: A process for the coproduction of 6-aminocapronitrile (ACN) and hexamethylenediamine (HMD) by treatment of adiponitrile (ADN) with hydrogen in the presence of a nickel-containing catalyst at temperatures not below room temperature and elevated hydrogen partial pressure in the presence or absence of a solvent comprises, after the conversion based on ADN and/or the selectivity based on ACN has or have dropped below a defined value (a) interrupting the treatment of ADN with hydrogen by stopping the feed of ADN and of the solvent, if used, (b) treating the catalyst at from 150 DEG to 400 DEG C. with hydrogen using a hydrogen pressure within the range from 0.1 to 30 MPa and a treatment time within the range from 2 to 48 h, and (c) then continuing the hydrogenation of ADN with the treated catalyst of stage (b).

Patent Agency Ranking